HE President of the Superior Health Council & HE Secretary General of HEC with Professor Michael Keogh, Director of Research Laboratories
Official ribbon cutting by HE the President of the Supreme Council of Health and HE the Secretary General of HEC at RCSI Bahrain Research Center
Manama, Bahrain, March 17, 2022 (GLOBE NEWSWIRE) — The Royal College of Surgeons of Ireland – Bahrain Medical University (RCSI Bahrain) has officially launched the state-of-the-art RCSI Bahrain Clinical and Biomolecular Research Center located in Bahrain Center Oncology Center, in partnership with King Hamad University Hospital (KHUH). An official opening ceremony was held under the high patronage of His Excellency Lieutenant General Dr Shaikh Mohammed bin Abdulla Al Khalifa, Chairman of the Supreme Health Council.
His Excellency Lieutenant General Dr. Shaikh Mohammed bin Abdulla Al Khalifa said in his address to the participants: “The need for the RCSI Bahrain Clinical and Biomolecular Research Center arose to help solve the health problems of the Kingdom of Bahrain and was the visionary idea of Professor Sameer Otoom – President of RCSI Bahrain and Major General (Dr) Shaikh Salman Al Khalifa – Chief Executive of King Hamad University Hospital, and was led by Professor Stephen Atkin, Director of the School of Studies Graduate Studies and Research at RCSI Bahrain. The research center will support the positioning of the Kingdom of Bahrain as a GCC healthcare hub and bring external funding and esteemed recognition to the Kingdom, making it a recognized regional center of excellence.
Her Excellency Dr Shaikha Rana bint Isa bin Duaij Al Khalifa – Secretary General of the Council for Higher Education and Vice Chairperson of the Board of Trustees of the Council for Higher Education, said in her address to the participants: “The research that will be undertaken here at the RCSI Center for Clinical and Biomolecular Research in Bahrain, and the results its discoveries will produce will not only lead to finding cheaper and more effective ways to cure some of the most prevalent diseases, but also to reduce financial burdens and logistical burdens on our public healthcare system, thereby improving the quality of services provided and advancing the quality of life of Bahrainis and residents. Medical research, like most forms of scientific research, is not only essential to the development of a society’s foundations, the cornerstones of education and national qualifications, but it is also one of the main engines which -tend Bahrain’s Vision 2030.
The official opening ceremony was attended by Her Excellency Dr. Shaikha Rana bint Isa bin Duaij Al Khalifa – Secretary General of the Council for Higher Education and Vice-Chairperson of the Board of Trustees of the Council for Higher Education; Her Excellency Dr. Maryam Al-Jalahma – Chief Executive Officer of the National Health Regulatory Authority (NHRA); Brigadier General Professor Hesham Yusuf Ali, Deputy Major General (Dr) Shaikh Salman Al Khalifa – Chief Executive Officer of King Hamad University Hospital (KHUH); Dr. Ahmed Al Ansari, Director General of Public Hospitals; Dr. Jaleela Al-Sayed Jawad, Director General of Primary Health Care Centers; Professor Elias Fadel – Director of the Bahrain Oncology Center and Chairman of the Bahrain National Tumor Council; Professor Fergal O’Brien, Deputy Vice-Chancellor for Research and Innovation and Head of the Tissue Engineering Research Group at RCSI in Dublin; Professor Stephen Atkin, Director of the School of Graduate Studies and Research – RCSI Bahrain, executives and staff from RCSI Bahrain and King Hamad University Hospital, and medical students from RCSI Bahrain especially interested in research.
With the recently established protocols for human clinical trials by the National Health Regulatory Authority (NHRA) and in line with the National Health Plan and Bahrain Vision 2030, the RCSI Bahrain Clinical and Biomolecular Research Center was established to promote teaching and research focused on prevailing health. diseases in the Kingdom of Bahrain such as diabetes, obesity and other health problems.
Professor Sameer Otoom, President of RCSI Bahrain, said: “The RCSI Bahrain Clinical and Biomolecular Research Center is a step forward in reinforcing RCSI Bahrain’s long-standing commitment to improving human health and healthcare. to patients through effort, innovative research and collaboration. We thank all our stakeholders involved in the creation of the Research Center and being part of an important milestone in the history of the University.
Located within the Bahrain Oncology Center, the RCSI Bahrain Clinical and Biomolecular Research Center provides a premier experience for clinical research patients and visitors, where RCSI researchers, clinicians and academic staff of Bahrain are working collaboratively to conduct pioneering translational research across a range of health science disciplines.
Professor Elias Fadel, Director of the Bahrain Oncology Center and President of the Bahrain National Tumor Council, pointed out that the opening of the Bahrain RCSI Clinical and Biomolecular Research Center at the Bahrain Oncology Center and in cooperation with King Hamad University Hospital, aims to improve education and develop research. and academic activities in various fields of medicine, especially in the field of stem cell sciences, under the supervision of a team of specialists. He also noted that research is an essential pillar to produce a database that contributes to the development of diagnostic and therapeutic capabilities, which ultimately contributes to raising the level of medical services in the Kingdom of Bahrain.
Brigadier General, Prof. Hesham Yusuf Ali, Deputy Major General (Dr) Shaikh Salman Al Khalifa – Director General of KHUH and Director General of Medical Affairs and Otorhinolaryngology Consultant at KHUH, hailed the cooperation between the Hospital, Bahrain Oncology Center and Royal College of Surgeons of Ireland – Bahrain Medical University in the field of advanced clinical and biomolecular research. This will in turn contribute to the development of research in a scientific environment, in accordance with the highest standards under the supervision of a group of experienced specialists and practitioners in this field. The Center is an essential part of any large medical institution, and it will be a daily activity that greatly enhances diagnostic and therapeutic capabilities, in many areas.
The Clinical and Biomolecular Research Center at RCSI Bahrain is divided into groups dedicated to specific research areas. One of the areas of expertise is conducting clinical trials to the highest international standards at the Clinical Trials Unit, where samples are taken from patients and immediately processed and analyzed, using latest technologies, by the clinical research team on site. The Unit has already undertaken three national clinical trials, having been appointed in 2020 by the Supreme Council of Health and the National Coronavirus (COVID-19) Medical Task Force to establish, facilitate and support the national response for all COVID-19 clinical tests. trial in Bahrain.
Another area of research is tissue regeneration, led by the Tissue Engineering Research Group, where the team explores the regeneration of soft tissues, such as skin and nerves, using smart biomaterials made in the laboratory and studying gene-activated scaffolds and cellular responses to wound healing. This research is applied to the treatment of diabetic foot ulcers and to the evaluation of the response of an anti-aging protein in improving wound healing.
A stem cell and genome engineering group has also been established to find cures and treatments for diabetic and neurological disorders, using pluripotent stem cells and CRISPR-mediated genome engineering. In addition, the Pancreatic Islet Cells group will study pancreatic islet cells, in order to improve cellular responses to disease, with the ultimate goal of curing type 1 and type 2 diabetes.
Professor Stephen Atkin, Director of the School of Graduate Studies and Research, who also oversees the research center and all research initiatives, said: “The Clinical and Biomolecular Research Center at RCSI Bahrain has access to cutting-edge technologies in clinical and translational medicine, to enable our researchers and clinicians to collaboratively conduct pioneering, patient-centered research that addresses key national, regional and global health challenges. With proactive regulations from the Ministry of Health and NHRA, the research center will support the transformation of Bahrain into a central hub for research and attract more global pharmaceutical manufacturers to the Bahraini market.
The cancer research group, in collaboration with the Bahrain Oncology Center, will further investigate the use of Sigma-1 receptor antagonists and data from in silico research in the treatment of breast cancer. In addition, the center will conduct pioneering DNA and RNA work to analyze genes and markers in clinical samples used for diagnosing diabetes and cancer.
About RCSI Bahrain
RCSI Bahrain is a constituent university of RCSI, which was established in Dublin, Ireland in 1784. RCSI Bahrain, an independent private university, opened its doors to a cohort of 28 medical students in 2004. It is a non-profit health organization. science institution focused on education and research to bring about positive change in all areas of human health worldwide. Today, the purpose-built campus is home to a student body of over 1,300 medical school students; Nursing and Midwifery and Postgraduate Studies and Research.
For more information, please visit www.rcsi.com/bahrain
RCSI Bahrain Instagram
RCSI Bahrain Facebook
RCSI Bahrain LinkedIn
CONTACT: Doaa Magdy Royal College of Surgeons in Ireland - Medical University of Bahrain (RCSI Bahrain) +97316660194 / +973 39929700 [email protected]